Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exact Sciences Corp (NASDAQ:EXAS)

22.99
Delayed Data
As of 3:59pm ET
 +1.91 / +9.06%
Today’s Change
5.36
Today|||52-Week Range
24.50
+72.08%
Year-to-Date
Exact Sciences Stock Soaring on Aetna Cologuard Coverage
12:40pm / TheStreet.com - Paid Partner Content
Why Exact Sciences Shares Are Already Up 65% in 2017
Mar 14 / MotleyFool.com - Paid Partner Content
Benzinga's Option Alert Recap From March 21
Mar 21 / Benzinga - Paid Partner Content
 

Today’s Trading

Previous close21.08
Today’s open22.40
Day’s range21.56 - 23.24
Volume4,730,387
Average volume (3 months)2,666,891
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)+4.68%
Earnings growth (this year)+9.25%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+151.99%
P/E ratioNM
Price/Sales13.76
Price/Book6.93

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+0.88+4.60%
JUNOJuno Therapeutics In...+0.65+3.22%
AVXSAveXis Inc+1.38+1.84%
HALOHalozyme Therapeutic...+0.74+5.47%
Data as of 4:02pm ET, 03/27/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$99.4M
Annual profit (last year)-$167.2M
Net profit margin-168.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Kevin T. Conroy
Chief Operating Officer, Director &
Senior VP
Maneesh K. Arora
Corporate headquarters
Madison, Wisconsin

Forecasts


Search for Jobs